The immunoblot assay indicated that the expression levels of DAPK and E-cadherin were decreased significantly in the ESCC tissue (P<0.05) when compared with the adjacent normal tissues. The gene discussed is DAPK1; the disease is esophageal squamous cell carcinoma.